Reference health
Patents as Quality Signals? The Implications for Financing Constraints on R&D
63/63 checkable references clean · checked 2026-08-27
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
9 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 63 checked references that resolve
resolves10.1111/1467-937x.t01-1-00020
The Sale of Ideas: Strategic Disclosure, Property Rights, and Contracting
resolves10.1016/s0883-9026(03)00038-7
Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups
resolves10.1016/s0378-4266(98)00038-7
The economics of small business finance: The roles of private equity and debt markets in the financial growth cycle
resolves10.1016/s1573-4412(07)06065-5
Chapter 65 Microeconometric Models of Investment and Employment
resolves10.1023/A:1022905102446
Is R & D Financially Constrained? Theory and Evidence from Irish Manufacturing
resolves10.1111/1468-0297.00683
Capital Market Imperfections, High‐Tech Investment, and New Equity Financing
resolves10.1007/s11187-009-9189-3
R&D investment and financing constraints of small and medium-sized firms
resolves10.1111/j.1530-9134.2010.00285.x
Financial Constraints: Routine Versus Cutting Edge R&D Investment
resolves10.1016/s0883-9026(97)84970-1
The impact of firmspecific capabilities on the amount of capital raised in an initial public offering: Evidence from the biotechnology industry
resolves10.1111/1468-5957.00220
Internal Capital Markets, Bank Borrowing, and Financing Constraints: Evidence from Belgian Firms
resolves10.2139/ssrn.1393725
To Be Financed or Not… - The Role of Patents for Venture Capital-Financing
resolves10.3386/w4096
Investment and Research and Development at the Firm Level: Does the Source of Financing Matter?
resolves10.2307/2696400
The Patent Paradox Revisited: An Empirical Study of Patenting in the U.S. Semiconductor Industry, 1979-1995
resolves10.2307/20076124
Are There Financing Constraints for R&D and Investment in German Manufacturing Firms?
resolves10.4337/9781849807760.00013
The Role of Patents and Licenses in Securing External Finance for Innovation
resolves10.5465/amj.2007.24162388
Innovation, Appropriability, And The Underpricing Of Initial Public Offerings
resolves10.1002/smj.4250150906
Measuring Competence? Exploring Firm Effects in Pharmaceutical Research
resolves10.2307/2109824
R & D and Internal Finance: A Panel Study of Small Firms in High-Tech Industries
resolves10.1162/rest_a_00227
Innovative Capability and Financing Constraints for Innovation: More Money, More Innovation?
resolves10.1257/aer.90.2.215
Knowledge Spillovers and Patent Citations: Evidence from a Survey of Inventors
resolves10.1016/0304-405x(76)90026-x
Theory of the firm: Managerial behavior, agency costs and ownership structure
resolves10.1162/003355397555163
Do Investment-Cash Flow Sensitivities Provide Useful Measures of Financing Constraints?
resolves10.1162/003355300554782
Investment-Cash Flow Sensitivities Are Not Valid Measures of Financing Constraints
resolves10.1287/mnsc.1060.0589
Impact of Licensing on Investment and Financing of Technology Development
resolves10.1002/smj.762
Managing liquidity in research‐intensive firms: signaling and cash flow effects of patents and alliance activities
resolves10.1016/0883-9026(85)90011-4
Criteria used by venture capitalists to evaluate new venture proposals
resolves10.1016/0304-405x(84)90023-0
Corporate financing and investment decisions when firms have information that investors do not have
resolves10.2307/2233173
Estimates of the Value of Patent Rights in European Countries During the Post-1950 Period
resolves10.1093/icc/dtp052
On young highly innovative companies: why they matter and how (not) to policy support them
resolves10.2307/2666998
Interorganizational Endorsements and the Performance of Entrepreneurial Ventures
The 9 references without a DOI — listed, not checked
no DOI — not checkedref13
no DOI — not checkedThe Market Valuation of Knowledge Assets in US and European Firms
no DOI — not checkedref30
no DOI — not checkedInnovation and Market Value
no DOI — not checkedref34
no DOI — not checkedref49
no DOI — not checkedFrascati Manual: Proposed Standard Practice for Surveys on Research and Experimental Development
no DOI — not checkedref71
no DOI — not checkedref72
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-08-27 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.2426072"><img src="https://citestamp.com/citestamped/10.2139/ssrn.2426072/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.2426072)